APO RESEARCH · REPORT
Natamycin
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Product & engineering
Understand the product.
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Selected research
Market Structure
Global Natamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
Read the full market overview
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
This report provides an overview of the global Natamycin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Natamycin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Natamycin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Natamycin market size, projected growth trends, production technologies, key applications, and end-use industries.
Natamycin Segment by Company
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Natamycin Segment by Type
Glucose-based
Lactose-based
Sodium chloride-based
Natamycin Segment by Application
Food
Medical
Others
Natamycin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natamycin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Natamycin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natamycin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Natamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Natamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Glucose-based
- Lactose-based
- Sodium chloride-based
Applications
- Food
- Medical
- Others
Companies covered
- Danisco
- DSM
- VGP
- Handary
- AMTECH BIOTECH
- Silver-Elephant
- Lanzhou Weiri
- Langfang Meihua
- Zhengzhou New Frey
- Chihon
- Jiaozuo Joincare
- Beijing Oriental Rada
- Pucheng Lifecome
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Natamycin Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Natamycin Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Natamycin Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Natamycin Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Natamycin Market Dynamics
- 2.1 Natamycin Industry Trends
- 2.2 Natamycin Industry Drivers
- 2.3 Natamycin Industry Opportunities and Challenges
- 2.4 Natamycin Industry Restraints
3 Natamycin Market by Manufacturers
- 3.1 Global Natamycin Revenue by Manufacturers (2021-2026)
- 3.2 Global Natamycin Sales by Manufacturers (2021-2026)
- 3.3 Global Natamycin Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Natamycin Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Natamycin Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Natamycin Manufacturers, Product Type & Application
- 3.7 Global Natamycin Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Natamycin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Natamycin Players Market Share by Revenue in 2025
- 3.8.3 2025 Natamycin Tier 1, Tier 2, and Tier 3
4 Natamycin Market by Type
- 4.1 Natamycin Type Introduction
- 4.1.1 Glucose-based
- 4.1.2 Lactose-based
- 4.1.3 Sodium chloride-based
- 4.2 Global Natamycin Sales by Type
- 4.2.1 Global Natamycin Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Natamycin Sales by Type (2021-2032)
- 4.2.3 Global Natamycin Sales Market Share by Type (2021-2032)
- 4.3 Global Natamycin Revenue by Type
- 4.3.1 Global Natamycin Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Natamycin Revenue by Type (2021-2032)
- 4.3.3 Global Natamycin Revenue Market Share by Type (2021-2032)
5 Natamycin Market by Application
- 5.1 Natamycin Application Introduction
- 5.1.1 Food
- 5.1.2 Medical
- 5.1.3 Others
- 5.2 Global Natamycin Sales by Application
- 5.2.1 Global Natamycin Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Natamycin Sales by Application (2021-2032)
- 5.2.3 Global Natamycin Sales Market Share by Application (2021-2032)
- 5.3 Global Natamycin Revenue by Application
- 5.3.1 Global Natamycin Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Natamycin Revenue by Application (2021-2032)
- 5.3.3 Global Natamycin Revenue Market Share by Application (2021-2032)
6 Global Natamycin Sales by Region
- 6.1 Global Natamycin Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Natamycin Sales by Region (2021-2032)
- 6.2.1 Global Natamycin Sales by Region (2021-2026)
- 6.2.2 Global Natamycin Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Natamycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Natamycin Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Natamycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Natamycin Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Natamycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Natamycin Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Natamycin Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Natamycin Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Natamycin Revenue by Region
- 7.1 Global Natamycin Revenue by Region
- 7.1.1 Global Natamycin Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Natamycin Revenue by Region (2021-2026)
- 7.1.3 Global Natamycin Revenue by Region (2027-2032)
- 7.1.4 Global Natamycin Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Natamycin Revenue (2021-2032)
- 7.2.2 North America Natamycin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Natamycin Revenue (2021-2032)
- 7.3.2 Europe Natamycin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Natamycin Revenue (2021-2032)
- 7.4.2 Asia-Pacific Natamycin Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Natamycin Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Natamycin Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Danisco
- 8.1.1 Danisco Company Information
- 8.1.2 Danisco Business Overview
- 8.1.3 Danisco Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Danisco Natamycin Product Portfolio
- 8.1.5 Danisco Recent Developments
- 8.2 DSM
- 8.2.1 DSM Company Information
- 8.2.2 DSM Business Overview
- 8.2.3 DSM Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 DSM Natamycin Product Portfolio
- 8.2.5 DSM Recent Developments
- 8.3 VGP
- 8.3.1 VGP Company Information
- 8.3.2 VGP Business Overview
- 8.3.3 VGP Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 VGP Natamycin Product Portfolio
- 8.3.5 VGP Recent Developments
- 8.4 Handary
- 8.4.1 Handary Company Information
- 8.4.2 Handary Business Overview
- 8.4.3 Handary Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Handary Natamycin Product Portfolio
- 8.4.5 Handary Recent Developments
- 8.5 AMTECH BIOTECH
- 8.5.1 AMTECH BIOTECH Company Information
- 8.5.2 AMTECH BIOTECH Business Overview
- 8.5.3 AMTECH BIOTECH Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 AMTECH BIOTECH Natamycin Product Portfolio
- 8.5.5 AMTECH BIOTECH Recent Developments
- 8.6 Silver-Elephant
- 8.6.1 Silver-Elephant Company Information
- 8.6.2 Silver-Elephant Business Overview
- 8.6.3 Silver-Elephant Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Silver-Elephant Natamycin Product Portfolio
- 8.6.5 Silver-Elephant Recent Developments
- 8.7 Lanzhou Weiri
- 8.7.1 Lanzhou Weiri Company Information
- 8.7.2 Lanzhou Weiri Business Overview
- 8.7.3 Lanzhou Weiri Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Lanzhou Weiri Natamycin Product Portfolio
- 8.7.5 Lanzhou Weiri Recent Developments
- 8.8 Langfang Meihua
- 8.8.1 Langfang Meihua Company Information
- 8.8.2 Langfang Meihua Business Overview
- 8.8.3 Langfang Meihua Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Langfang Meihua Natamycin Product Portfolio
- 8.8.5 Langfang Meihua Recent Developments
- 8.9 Zhengzhou New Frey
- 8.9.1 Zhengzhou New Frey Company Information
- 8.9.2 Zhengzhou New Frey Business Overview
- 8.9.3 Zhengzhou New Frey Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Zhengzhou New Frey Natamycin Product Portfolio
- 8.9.5 Zhengzhou New Frey Recent Developments
- 8.10 Chihon
- 8.10.1 Chihon Company Information
- 8.10.2 Chihon Business Overview
- 8.10.3 Chihon Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Chihon Natamycin Product Portfolio
- 8.10.5 Chihon Recent Developments
- 8.11 Jiaozuo Joincare
- 8.11.1 Jiaozuo Joincare Company Information
- 8.11.2 Jiaozuo Joincare Business Overview
- 8.11.3 Jiaozuo Joincare Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Jiaozuo Joincare Natamycin Product Portfolio
- 8.11.5 Jiaozuo Joincare Recent Developments
- 8.12 Beijing Oriental Rada
- 8.12.1 Beijing Oriental Rada Company Information
- 8.12.2 Beijing Oriental Rada Business Overview
- 8.12.3 Beijing Oriental Rada Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Beijing Oriental Rada Natamycin Product Portfolio
- 8.12.5 Beijing Oriental Rada Recent Developments
- 8.13 Pucheng Lifecome
- 8.13.1 Pucheng Lifecome Company Information
- 8.13.2 Pucheng Lifecome Business Overview
- 8.13.3 Pucheng Lifecome Natamycin Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Pucheng Lifecome Natamycin Product Portfolio
- 8.13.5 Pucheng Lifecome Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Natamycin Value Chain Analysis
- 9.1.1 Natamycin Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Natamycin Production Mode & Process
- 9.2 Natamycin Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Natamycin Distributors
- 9.2.3 Natamycin Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst